RT Journal Article
SR Electronic
T1 A Mendelian randomization study of telomere length and blood-cell traits
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.05.30.20117978
DO 10.1101/2020.05.30.20117978
A1 Adams, Charleen D.
A1 Boutwell, Brian B.
YR 2020
UL http://medrxiv.org/content/early/2020/06/03/2020.05.30.20117978.abstract
AB Whether telomere attrition reducing proliferative reserve in blood-cell progenitors is causal has important public-health implications. Mendelian randomization (MR) is an analytic technique using germline genetic variants as instrumental variables. If certain assumptions are met, estimates from MR should be free from most environmental sources of confounding and reverse causation. Here, two-sample MR is performed to test whether longer telomeres cause changes to hematological traits. Summary statistics for genetic variants strongly associated with telomere length were extracted from a genome-wide association (GWA) study for telomere length in individuals of European ancestry (n=9190) and from GWA studies of blood-cell traits, also in those of European ancestry (n∼173,000 participants). A standard deviation increase in genetically influenced telomere length increased red blood cell (RBC) and white blood cell (WBC) counts, decreased mean corpuscular hemoglobin (MCH) and mean cell volume (MCV), and had no observable impact on mean corpuscular hemoglobin concentration (MCHC), red cell distribution width (RDW), hematocrit, or hemoglobin. Sensitivity tests for pleiotropic distortion were mostly inconsistent with glaring violations to the MR assumptions. Similar to how germline mutations in TERT can lead to bone-marrow failure, these data provide evidence that genetically influenced common variation in telomere length impacts hematologic traits in the population.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNo funding received.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:IRB/oversight was not needed, as this manuscript did not involve human subjects. Only summary-level statistical data, already in the public sphere, were used for analyses.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData availability. All data sources used for SNP-exposure and SNP-outcome associations are publicly available. The summary data for the telomere length instruments are available in Haycock et al. (2017)20. The nine hematological outcome GWA studies used for these analyses are accessible within MR-Base: http://www.mrbase.org/.MRMendelian randomizationRBCred blood cellWBCwhite blood cellRetreticulocyteMCHmean corpuscular hemoglobinMCVmean cell (corpuscular) volumeMCHCmean corpuscular hemoglobin concentrationRDWred blood cell distribution widthHcthematocritHgbhemoglobinGWAgenome-wide associationHSChematopoietic stem cellBMFbone marrow failureIBMFSinherited bone marrow failure syndromes